Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Sirolimus 2% for Plantar Blistering in EBS
NCT03016715Phase 2Unknown
- Sponsor
- Premier Specialists
- Start
- May 2016
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in epidermolysis bullosa simplex (EBS), sponsored by Premier Specialists. Status: unknown.
02
Drugs
sirolimus
03
Conditions
epidermolysis bullosa simplex (EBS)
Beyond the preview
Go deeper on NCT03016715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03016715.